Explore Caplin Point Laboratories
- Price history1-year return +22.00% vs Nifty 50 +14.20%
- Technical analysis200-day SMA ₹2,353.74 · RSI (14) 58.5
- Pivot pointsDaily pivot ₹2,674.70 · R1 ₹2,714.82 · S1 ₹2,634.58
- Financial resultsMar 2020 revenue ₹863 crore · net profit ₹215 crore
- Balance sheetTotal assets ₹13,700 crore · debt/equity 0.13 (Mar 2022)
- Cash flowOperating cash flow ₹1,400 crore · free cash flow ₹950 crore (Mar 2022)
- Shareholding patternPromoter holding 70.57% (0.00 pp vs 31-MAR-2026) · FII 5.75%
- Dividend historyLast dividend ₹4.00/share, ex-date 18 Sep 2026
- News & announcementsLatest: CAPLIPOINT Reports Quarterly Financial Results & Operating Metrics Update
- Peer comparisonRanks 28th of 71 by market cap in Pharmaceuticals
Company informationCaplin Point Laboratories — overview, financials & FAQs
Caplin Point Laboratories (CAPLIPOINT) share price is tracked live on this page, with the intraday move, day range, historical chart, financial results, shareholding pattern and technical levels for both NSE and BSE.
CAPLIPOINT has been listed on the NSE since 23 June 2014 and trades under ISIN INE475E01026, with a face value of ₹2. It is classified by the NSE under Healthcare.
Prices update through the trading session. Figures on this page are for information only and are not a recommendation to buy or sell.
Caplin Point Laboratories key information
| Company | Caplin Point Laboratories |
|---|---|
| NSE symbol | CAPLIPOINT |
| Sector | Healthcare |
| ISIN | INE475E01026 |
| Listed on NSE | 23 June 2014 |
| Face value | ₹2 |
| Series | EQ (rolling settlement, intraday allowed) |
| Exchanges | NSE and BSE |
| Previous close | ₹2,336.40 |
| 52-week range | ₹1,500.30 – ₹2,990.00 |
Caplin Point Laboratories Share Price Today
The live Caplin Point Laboratories (CAPLIPOINT) share price above shows the last traded price, the change and percentage change for the session, and the day's open, high, low and previous close. Use the exchange toggle to switch between the NSE and BSE quote.
Caplin Point Laboratories Share Price Chart and History
The full Caplin Point Laboratories price history — monthly open, high, low and close, and returns against the Nifty 50 — is on its own page.
Caplin Point Laboratories Financials and Quarterly Results
Caplin Point Laboratories's quarterly results, annual profit and loss, balance sheet and cash flow are each on their own page, with every reported period.
Caplin Point Laboratories Shareholding Pattern
The Caplin Point Laboratories shareholding pattern, quarter by quarter with the change in each holder group, is on its own page.
Caplin Point Laboratories Dividend, Bonus and Stock Split History
Every Caplin Point Laboratories dividend, bonus issue and stock split, with ex-dates and record dates, is listed on its own page.
Caplin Point Laboratories 52-Week High and Low
Over the last year Caplin Point Laboratories (CAPLIPOINT) has traded between ₹1,500.30 and ₹2,990.00. The 52-week range is the simplest read on where the current price sits against its own recent history.
Caplin Point Laboratories Technical Analysis and Pivot Levels
Caplin Point Laboratories's moving averages, RSI, MACD and trend, and its pivot-point support and resistance levels, are on their own pages.
Healthcare sector peers
- Country Club Hospitality & Holidays Limited
- The Byke Hospitality Limited
- Cipla Limited
- Brooks Laboratories Limited
- Cohance Lifesciences Limited
- Blue Jet Healthcare Limited
- Concord Biotech Limited
- Bliss GVS Pharma Limited
- Divi's Laboratories Limited
- Biofil Chemicals & Pharmaceuticals Limited
- Dr. Reddy's Laboratories Limited
- Biocon Limited
Browse more stocks
- Capital Trust Limited
- Capital Small Finance Bank Limited
- Carborundum Universal Limited
- Capillary Technologies India Limited
- CARE Ratings Limited
- Capacit'e Infraprojects Limited
- Carraro India Limited
- Cantabil Retail India Limited
- Cartrade Tech Limited
- Canara HSBC Life Insurance Company Limited
- Carysil Limited
- Can Fin Homes Limited
Tools for trading CAPLIPOINT
Caplin Point Laboratories share price — frequently asked questions
What is the Caplin Point Laboratories share price today?
The live Caplin Point Laboratories (CAPLIPOINT) price is shown at the top of this page, together with the day's change, open, high, low and previous close for both NSE and BSE. It updates through the trading session.
What is the NSE symbol and ISIN for Caplin Point Laboratories?
Caplin Point Laboratories trades on the NSE under the symbol CAPLIPOINT, with ISIN INE475E01026 in the EQ series.
When was Caplin Point Laboratories listed on the stock exchange?
Caplin Point Laboratories (CAPLIPOINT) has been listed on the National Stock Exchange since 23 June 2014. Its shares carry a face value of ₹2.
Where can I see Caplin Point Laboratories quarterly results and financials?
The Caplin Point Laboratories financial results page lists every reported quarter and financial year — revenue, operating profit, net profit, margins and EPS — and the balance sheet and cash flow pages carry the other two statements, so you can compare each CAPLIPOINT reporting period against the last.
Does Caplin Point Laboratories pay a dividend?
Every dividend, bonus issue and stock split Caplin Point Laboratories has declared is listed on the Caplin Point Laboratories dividend history page, with the ex-date, record date and amount per share as announced on the exchanges.
What is the Caplin Point Laboratories shareholding pattern?
The Caplin Point Laboratories shareholding pattern page breaks CAPLIPOINT down by promoter, foreign institutional, domestic institutional and public holding for each quarter, with the change from the previous quarter.
Which sector does Caplin Point Laboratories belong to?
The NSE classifies Caplin Point Laboratories under Healthcare. You can compare it against other Healthcare stocks from the sector peers listed on this page.
How do I buy Caplin Point Laboratories shares?
You need a trading and demat account to buy CAPLIPOINT on the NSE or BSE. Once your account is active you can place a buy or sell order from this page. Nothing here is a recommendation — please make your own assessment.